Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.

Ayers K, Byrne LM, DeMatteo A, Brown NJ
Hypertension. 2012 59 (4): 893-8

PMID: 22353614 · PMCID: PMC3402551 · DOI:10.1161/HYPERTENSIONAHA.111.189589

MeSH Terms (20)

Adrenergic beta-Antagonists Adult Benzopyrans Blood Glucose Blood Pressure Double-Blind Method Ethanolamines F2-Isoprostanes Female Heart Rate Homeostasis Humans Insulin Resistance Male Metabolic Syndrome Metoprolol Middle Aged Nebivolol Oxidative Stress Plasminogen Inactivators

Connections (1)

This publication is referenced by other Labnodes entities: